华恒生物: 安徽华恒生物科技股份有限公司关于选举独立董事及调整专门委员会及委员的公告

Group 1 - The company held its 23rd meeting of the fourth board of directors, where it approved the election of a new independent director and adjustments to the specialized committees and their members [1][2] - Independent director Zhang Qifeng will step down after serving for six years, and the company will continue to fulfill his duties until a new independent director is elected at the shareholders' meeting [1][2] - Chen Jizhong has been nominated as the independent director candidate, pending approval from the Shanghai Stock Exchange and the shareholders' meeting [2][5] Group 2 - The company has restructured its specialized committees, changing the original nomination, remuneration, and assessment committee into separate nomination and remuneration committees [2][3] - The new composition of the specialized committees includes the Strategy and ESG Committee, Audit Committee, Nomination Committee, and Remuneration and Assessment Committee, each consisting of three members [3] - Chen Jizhong will serve as the convener of the Audit Committee upon his election as an independent director [3]